Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory…
New Year’s Holiday, Jobless Claims, Pending Home Sales, Fed Minutes
Getty Investors will ring in 2026 after seeing major market indexes rise by more than double digits in…
Tariff, Inflation Fears Led Fed To Avoid Rate Cut In July, Meeting Minutes Show
Bloomberg / Contributor / Getty Images Meeting minutes show that Federal Reserve officials are hesitant to cut interest…